by EmpathiCSubstanceS | Feb 8, 2020 | Anxiety
Following the popularity of ‘microdosing’ psychedelics to improve productivity, some are turning to these substances for career clarity. Paul Austin and Matt Gillespie are trying to retrace their steps along a path shrouded by redwood trees. All things...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Depression, Kambo
Marking an impressive milestone in the development of MDMA-assisted psychotherapy for PTSD, the U.S. Food and Drug Administration (FDA) has approved the treatment for Expanded Access, allowing certain patients access to the therapy before full market approval is...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Bipolar Disorder, Depression, PTSD
Many use kratom to quit opioids; others just want to get high. There’s a push to regulate the plant-derived drug—but experts disagree on its safety. By her mid-20s, Faith Day was out of jail but homeless. She was also addicted to a substance now too legally...
by EmpathiCSubstanceS | Feb 8, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, PTSD
One of the more compelling areas of research currently being investigated in the world of psychedelic science is psilocybin-assisted psychotherapy to improve emotional well-being in patients with life-threatening cancer. A new study is offering the first long-term...
by EmpathiCSubstanceS | Feb 8, 2020 | Cancer, Pain, PTSD
A team of researchers from King’s College London has, for the first time, imaged the brains of patients with psychosis under the influence of cannabidiol (CBD). The study demonstrates the anti-psychotic potential of CBD, suggesting large clinical trials are necessary....
